Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in Eur J Pharmacol

Retrieve available abstracts of 18 articles:
HTML format



Single Articles


    October 2022
  1. GONG Y, Kong B, Shuai W, Chen T, et al
    Effect of sotagliflozin on ventricular arrhythmias in mice with myocardial infraction.
    Eur J Pharmacol. 2022;936:175357.
    PubMed     Abstract available


  2. VAN BAVEL JJA, Beekman HDM, van Weperen VYH, van der Linde HJ, et al
    IKs inhibitor JNJ303 prolongs the QT interval and perpetuates arrhythmia when combined with enhanced inotropy in the CAVB dog.
    Eur J Pharmacol. 2022;932:175218.
    PubMed     Abstract available


    August 2022
  3. SHEN S, Duan J, Hu J, Qi Y, et al
    Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction.
    Eur J Pharmacol. 2022;929:175126.
    PubMed     Abstract available


    July 2022
  4. NOGAWA H, Muraki Y, Kawai T, Kuninishi Y, et al
    Pharmacological characterisation of electrocardiogram J-Tpeak interval in conscious Guinea pigs.
    Eur J Pharmacol. 2022;927:175065.
    PubMed     Abstract available


  5. HAN Y, Xiong C, Zhang LZ, Wang YD, et al
    Antagonism of N/OFQ attenuates externalization of beta1-adrenergic receptor and ventricular arrhythmias in acute myocardial ischemia rat model.
    Eur J Pharmacol. 2022;929:175139.
    PubMed     Abstract available


    June 2022
  6. PONNIAN SMP
    Preventive effects of (-) epicatechin on tachycardia, cardiac hypertrophy, and nuclear factor- kappaB inflammatory signaling pathway in isoproterenol-induced myocardial infarcted rats.
    Eur J Pharmacol. 2022;924:174909.
    PubMed     Abstract available


    January 2022
  7. BALLET V, Bohme GA, Brohan E, Boukaiba R, et al
    In vitro ion channel profile and ex vivo cardiac electrophysiology properties of the R(-) and S(+) enantiomers of hydroxychloroquine.
    Eur J Pharmacol. 2022;915:174670.
    PubMed     Abstract available


    December 2021
  8. THOMET U, Amuzescu B, Knott T, Mann SA, et al
    Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept.
    Eur J Pharmacol. 2021;913:174632.
    PubMed     Abstract available


  9. KILFOIL P, Feng SL, Bassyouni A, Lee T, et al
    Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters.
    Eur J Pharmacol. 2021;912:174584.
    PubMed     Abstract available


    November 2021
  10. FANG J, Kong B, Shuai W, Xiao Z, et al
    Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia.
    Eur J Pharmacol. 2021 Nov 5:174622. doi: 10.1016/j.ejphar.2021.174622.
    PubMed     Abstract available


  11. YANG HW, Lin CY, Lin FZ, Yu PL, et al
    Phosphodiesterase-1 inhibitor modulates Ca(2+) regulation in sirtuin 1-deficient mouse cardiomyocytes.
    Eur J Pharmacol. 2021;910:174498.
    PubMed     Abstract available


  12. JIE LJ, Li YD, Zhang HQ, Mao L, et al
    Mechanisms of gefitinib-induced QT prolongation.
    Eur J Pharmacol. 2021;910:174441.
    PubMed     Abstract available


    September 2021
  13. NAFFAA MM, Al-Ewaidat OA
    Ligand modulation of KCNQ-encoded (KV7) potassium channels in the heart and nervous system.
    Eur J Pharmacol. 2021;906:174278.
    PubMed     Abstract available


  14. GERGS U, Bruckner T, Hofmann B, Neumann J, et al
    The proarrhythmic effects of hypothermia in atria isolated from 5-HT4-receptor-overexpressing mice.
    Eur J Pharmacol. 2021;906:174206.
    PubMed     Abstract available


    August 2021
  15. BELEM-FILHO IJA, Brasil TFS, Fortaleza EAT, Antunes-Rodrigues J, et al
    A functional selective effect of oxytocin secreted under restraint stress in rats.
    Eur J Pharmacol. 2021;904:174182.
    PubMed     Abstract available


    June 2021
  16. BAI S, Wang X, Wu H, Chen T, et al
    Cardioprotective effect of anisodamine against ischemia/reperfusion injury through the mitochondrial ATP-sensitive potassium channel.
    Eur J Pharmacol. 2021;901:174095.
    PubMed     Abstract available


    May 2021
  17. SAPONARA S, Fusi F, Iovinelli D, Ahmed A, et al
    Flavonoids and hERG channels: Friends or foes?
    Eur J Pharmacol. 2021;899:174030.
    PubMed     Abstract available


    April 2021
  18. SILVA EAP, Carvalho JS, Dos Santos DM, Oliveira AMS, et al
    Cardiovascular effects of farnesol and its beta-cyclodextrin complex in normotensive and hypertensive rats.
    Eur J Pharmacol. 2021 Apr 2:174060. doi: 10.1016/j.ejphar.2021.174060.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: